Publications

Study #CategoryCitationPublication
Type
Year
REG001 PancreasNichols R, Morris C, Dunn M, Prabhu K, Hartsell W, Cahlon O, Apisarnthanarax S, McGee L, Vargas C. Postoperative Proton Therapy for Pancreatic Cancer Patients Enrolled on the Proton Collaborative Group (PCG) Registry. PTCOG 2017.
Conference Poster2017
REG001BreastZheng Y, Prabhu K, Chang A, Larson G, Vargas C, Wong J. Toxicity of Uniform Scanning Proton Therapy for Breast Cancer. PTCOG 2017.Conference Poster2017
REG001BreastVargas C, Fega R, Hartsell W, Larson G, Fang C, Nichols E, Rossi C, Rosen L, Tsai H. Multi-institutional Results of Breast Proton Radiation Therapy: An Analysis of the PCG Registry. PTCOG 2017.Conference Presentation2017
REG001LungBadiyan S, Hartsell W, Larson G, Tsai H, Feigenberg S, Simone C, Mohindra P, Vargas C, Rengan R, Zeng J, Wilkinson B. Clinical Outcomes of Patients with Recurrent Lung Cancer Re-irradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial. PTCOG 2017.Conference Presentation2017
REG001Head & NeckGamez M, Hartsell W, Tsai H, Laramore G, Larson G, Badiyan S, Rossi C, Wilkinson B, Buras M, Patel S. Sinonasal Cancer Patients Treated with Proton Therapy: The Proton Collaborative Group (PCG) Experience. PTCOG 2017.Conference Presentation2017
REG001ProstateChuong M, Vargas C, Hartsell W, Kaiser A, Rossi C, Laramore G, Wilkinson B, Larson G, Tsai H. Minimal Toxicity After Proton Beam Therapy for Prostate and Pelvic Nodal Irradiation: Results from the Proton Collaborative Group REG001-09 Trial. PTCOG 2017.Conference Presentation2017
REG001LiverChuong M, Smith A, Hartsell W, Larson G, Tsai H, Rossi C, Vargas C. Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Group REG001-09 Trial. Gastrointestinal Cancers Symposium 2017.Conference Poster2017
REG001ProstateConterato J. Assessment of Acute Toxicity in Prostate Cancer Patients using Hydrogel Spacer During Proton Therapy. RSNA 2016.Conference Presentation2016
REG001GeneralSchmidt S. Proton Therapy Maintains or Improves the Performance Status in Reirradiation Patients. PTCOG NA 2016.Conference Presentation2016
REG001ProstateConterato J. Reduction in Rectal Dose in Prostate Cancer Patients Using Hydrogel Spacer During Proton Therapy. PTCOG NA 2016.Conference Presentation2016
REG001CNSWilkinson J, Morgan H, Gondi V, Larson G, Hartsell W, Laramore G, Halasz L, Vargas C, Keole S, Grosshans D, Shih H, Mehta M. Low Levels of Acute Toxicity Associated with
Proton Therapy for Low Grade Gliomas: A Proton Collaborative Group Study.
ASTRO 2016.
Conference Poster2016
REG001LungBadiyan S. Clinical Outcomes of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Proton Beam Therapy on the Proton Collaborative Group Prospective Registry Trial. PTCOG 2016.Conference Presentation2016
REG001EsophagusZeng J. Proton Therapy Posterior Beam Approach with PBS for Esophageal Cancer: Clinical Outcome, Dosimetry, & Feasibility. PTCOG 2016.Conference Presentation2016
REG001LymphomaHoppe B, Hartsell W. Proton Therapy Patterns-of-Care and Early Outcomes for Hodgkin Lymphoma: Results from the Proton Collaborative Group Registry. PTCOG 2016.Conference Presentation2016
REG001GINichols R, Morris C, Dunn M, Prabhu K, McGee L, Hartsell W, Cahlon O, Apisarnthanarax S, Vargas C. Postoperative proton therapy for pancreatic cancer patients enrolled on the Proton Collaborative Group (PCG) registry. PTCOG 2016.Conference Poster2016
REG001EsophagusChuong M, Larson G, Hartsell W, Tsai H, Zeng J, Rossi C, Wilkinson J, Badiyan S, Vargas C. Limited Toxicity After Proton Beam Therapy for Esophageal Cancer: Outcomes from the Proton Collaborative Group. PTCOG 2016.Conference Poster2016
REG001GeneralMehta M, Dunn M, Hoppe B, Laramore G, Chang A, Vargas C, Hartsell W.The Proton Collaborative Group’s Research Portfolio: An Update from the PTCOG 2015 Presentation. PTCOG 2016.Conference Poster2016
REG001PhysicsRana S, Cheng C, Zhao L, Park S, Larson G, Vargas C, Dunn M, Zheng Y. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles. Journal of Medical Radiation Sciences; 11 May 2016. Journal Article2016
REG001GINichols RC. Proton Collaborative Group registry of patients treated for pancreatic cancer- enrollment and preliminary outcomes. PTCOG 2015.Conference Presentation2015
GU002GenitourinaryVargas C, Hartsell W, Dunn M, Keole S, Doh L, Eisenbeisz E, Larson G.
Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer Interim Results of a Randomized Trial PCG GU 002. American Journal of Clinical Oncology 2015.
Journal Article2015
BRE007BreastChang A, Qu L, Dunn M, Sindwani R, Benda R, Adams T, Prabhu K. Initial results of a multi-institutional proton accelerated partial breast irradiation trial. PTCOG 2015.Conference Presentation2015
REG001
GeneralBevolo T, Dunn M, Laub S. Patient weight fluctuations during proton therapy treatment: Safety and financial implications. PTCOG 2015. Conference Poster2015
REG001GeneralDunn M, Brown C, Hagarty E, Hartsell W, Tsai H, Laramore G, Vargas C.Enrollment trends of a large volume prospective registry hosted by the Proton Collaborative Group. PTCOG 2015.Conference Poster2015
NAGeneralDunn M, Eisenbeisz E. The myth of randomized experiments as the gold standard when research comparative effectiveness. PTCOG 2015.Conference Poster2015
REG001Lung Dunn M, Hoppe B, Simone C. Trial eligibility of locally advanced NSCLC patients receiving proton therapy using multi-institutional registry data: Are current cooperative group trials being designed for the right patients? World Conference on Lung Cancer 2015.Conference Presentation2015
REG001BreastIftekaruddin Z, McGee L, Maliekel J, Dunn M, Hartsell W. Acute toxicity outcomes in breast cancer patients treated with adjuvant proton therapy. PTCOG 2015. Conference Poster2015
REG001GenitourinaryRana S, Larson G, Vargas C, Dunn M, Zheng Y. Pencil beam scanning versus uniform scanning: Treatment planning for unilateral hip prosthesis prostate cancer. PTCOG 2015.Conference Poster2015
REG001GenitourinaryRana S, Larson G, Vargas C, Dunn M, Zheng Y. Intensity modulated proton therapy versus uniform scanning proton therapy: Treatment planning study of the prostate cancer in patients with a unilateral metallic hip prosthesis. http://protonjournal.org/index.php/jpt/article/view/jpt.11.3 Journal of Proton Therapy. 2015; 1:113. Journal Article2015
GU002Genitourinary Vargas C, Hartsell W, Dunn M, Larson G. Hypofractionated vs. standard fractionated proton beam therapy for low risk prostate cancer: Interim results of a randomized trial- PCG GU002. PTCOG 2015. Conference Presentation2015
REG001GeneralMehta M, Dunn M, Hoppe B, Laramore G, Chang A, Vargas C, Hartsell W. Fact or Fiction: Proton beam therapy is primarily for patients with prostate cancer. ASTRO 2015.Conference Poster2015
REG001GeneralDunn M, Mehta M, Hoppe B, Laramore G, Chang A, Vargas C, Hartsell W. The Proton Collaborative Group's research portfolio. ASTRO- Big Data 2015. Conference Poster2015
REG001
GeneralMehta M, Dunn M, Hoppe B, Laramore G, Chang A, Vargas C, Hartsell W. The Proton Collaborative Group's research portfolio. PTCOG 2015. Conference Presentation2015
REG001GenitourinaryRana S, Larson G, Vargas C, Dunn M, Zheng Y. Correlating tissue toxicities with EUD and NTCP for metallic prosthesis prostate cancer patients in proton therapy. PTCOG 2015.Conference Poster2015
REG001GenitourinaryCuaron J, Harris A, Chon B, Tsai H, Larson G, Hartsell W, Hug E, Cahlon O. Anterior-oriented proton beams for prostate cancer: A multi-institutional experience. http://informahealthcare.com/doi/abs/10.3109/0284186X.2014.986288 Acta Oncologica; posted online 15Jan15.Journal Article2015
REG001GenitourinaryHartsell W, Dunn M, Larson G, Vargas C. Hypofractionated vs standard fractionation proton beam therapy for early stage prostate cancer: Interim results of a randomized prospective trial. ARS 2015.Conference Presentation2015
REG001BreastMcGee L, McGue M, Dunn M, Schmidt S, Kaplan D, Pankuch M, Hartsell W. Proton therapy on an incline beam line: Acute toxicity outcomes in locally advanced breast cancer patients. ARS 2015. Conference Poster 2015
GU002GenitourinaryVargas C, Dunn M, Hartsell W, Larson G.
Interim analysis: Prospective trial of proton standard-fractionation vs. hypo-fractionation. PTCOG-NA 2014.
Conference Presentation 2014
REG001BreastSchmidt S, Dunn M, Pankuch M, Kaplan D, McGee L, Hartsell W.
Treatment of locally advanced breast cancer: Case studies of proton and photon comparative plans. PTCOG-NA 2014.
Conference Presentation2014
REG001BreastSchmidt S, Pankuch M, Kaplan D, McGee L, Dunn M, Hartsell W.
Adjuvant treatment of locally advanced breast cancer using uniform scanning and pencil beam scanning proton therapy. PTCOG-NA 2014.
Conference Presentation2014
REG001GeneralDunn M, Vargas C, Hartsell W. The Proton Collaborative Group's prospective chart review registry- Comments from the first five years. PTCOG-NA 2014. Conference Presentation2014
REG001CNSGondi V. Outcomes following large-volume re-irradiation using proton therapy for recurrent malignant glioma. PTCOG-NA 2014.Conference Oral Poster 2014
REG001GeneraldeLongpre R, Pruneau A. The future of proton therapy: Pencil beam scanning. ASRT 2014. Conference Presentation2014
REG001Peds CNSLai J-S. Do children with brain tumors have worse quality of life than the general population? ISPNO 2014.Conference Presentation2014
REG001Peds CNS Chang JH-C, Confer M, Chang A, Goldman S, Dunn M, Hartsell W. Prospective study on pediatric patients with atypical teratoid rhabdoid tumors (ATRT) of the central nervous system (CNS). ISPNO 2014, SIOP 2014, PTCOG 2014, RSNA 2014, PTCOG-NA 2014.Conference Poster/ Presentation2014
REG001GenitourinaryDunn M, McClinitic C, Ramirez S. Depression scores pre and post treatment for 414 men with prostate cancer using Proton Collaborative Group data. PTCOG 2014, PTCOG-NA 2014.Conference Poster/ Presentation2014
REG001Adult CNSJefferis J, Hartsell W, Chang J, Gondi V. Minimal acute toxicities following high-dose proton therapy for spinal tumors. ASTRO 2014, SNO 2014, PTCOG-NA 2014.Conference Poster/ Presentation2014
REG001GenitourinaryRana S, Pokharel S, Zheng Y, Zhao L, Vargas C, Cersonsky N. Treatment planning case study comparing uniform scanning proton therapy, RapidArc and intensity modulated radiation therapy for a synchronous bilateral lung cancer. International Journal of Cancer Therapy and Oncology 2014; 2(2):020216
http://ijcto.org/index.php/IJCTO/article/view/020216
Journal Article2014
REG001GenitourinaryRana S, Cheng C, Zheng Y, Hsi W, Zeidan O, Schreuder N, Vargas C, Larson G. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy. Journal of Applied Clinical Medical Physics 2014; 15(3): 4611.
http://jacmp.org/index.php/jacmp/article/view/4611
Journal Article2014
REG001Head & NeckHartsell S, Pankuch M, Lopes C, Chang J, Dunn M, Sweeney P, Kapur R, Hartsell W. 3-D treatment planning for proton therapy of ocular melanoma: Evaluations of organs at risk. PTCOG-NA 2014.Conference Presentation2014
REG001GenitourinaryRana S, Cheng C, Zheng Y, Risalvato D, Cersonsky N, Ramirez E, Zhao L, Larson G, Vargas C. Proton therapy vs. VMAT for prostate cancer: a treatment planning study. International Journal of Particle Therapy 2014; 1(1):22-33
Link: http://theijpt.org/doi/full/10.14338/IJPT.13-00003.1
Journal Article2014
REG001BreastMcGee L. Breast cancer treatment with uniform scanning proton therapy on an incline beam line. PTCOG-NA 2014. Conference Presentation2014
REG001CNS Gondi V, Jefferis J, Hartsell W, Chang J. Minimal acute toxicities following high-dose proton therapy for spinal tumors. PTCOG-NA 2014.Conference Presentation2014
REG001PhysicsHsi W, Fagundes M, Zeidan O, Hug E, Schreuder N. Image-guided method for TLD-based in vivo rectal dose verification with endorectal balloon in proton therapy for prostate cancer. Med. Phys. 40 (5), May 2013. http://online.medphys.org/resource/1/mphya6/v40/i5/p051715_s1?isAuthorized=no.Journal Article2013
REG001GeneralHahn K, Piper A, Rodriquez R. Development of a Proton Therapy Multi-Site Registry.Society of Clinical Research Associates (SOCRA). February 2013; 75:77.Journal Article & Conference Presentation2013
REG001GenitourinaryHartsell W., Deeke H., Gans S., Yoo C., Hartsell S., Corbett A., Chang J., Vargas C. Prostate size Does Not Correlate with Acute Genitourinary Symptoms in Patients Treated with Proton Beam Therapy. Amer Soc Thera Rad Onc (ASTRO) Symposium-Annual Meeting; September 22-25, 2013; Atlanta, GA-USA.Conference Presentation2013
REG001PhysicsSchmidt S. Simulation, planning, and delivery of breast/chest wall treatment using uniform scanning proton beam therapy. American Association of Medical Dosimetrist; Aug 2013; Anchorage, AConference Presentation2013
REG001PhysicsChang J, Gans S, Pankuch M, Hahn K, Abruscato L, Hartsell W. Dosimetric comparisons of Uniform scanning proton Beam Therapy (US PBT) versus Intensity Modulated Radiation Therapy (IMRT) for Mediastinal Malignancies. Amer Soc Thera Rad Onc (ASTRO) Symposium-Annual Meeting; Oct 28-31, 2012; Boston, MA-USA .Conference Presentation2012
REG001PhysicsSchmidt S, Gans S, Mingcheng G, Pankuch M, Chang J, Hahn K, Abruscato L, Hartsell W. An Evalustion of the Use of US PBT Helical XRT, and E. Compensator XRT for Left Chest Wall/Nodes.Particle Therapy Cooperative Group (PTCOG) Symposium-Annual Meeting; May 14-19, 2012; Seoul, Korea. Conference Presentation2012
REG001GenitourinaryKeole S, Zeidan O, Rodriquez R, Smidbush D, Hahn K, Nordhues E, Larson G, Barringer B, Doh L, Zheng Y, Vargas C. Proton Therapy for Prosate Cancer: The Procure Oklahoma Experience.Amer Soc Thera Rad Onc (ASTRO); Symposium-Annual Meeting; Oct 28-31, 2012; Boston, MA-USA .Conference Presentation2012
REG001PhysicsSchmidt S, Hecksel D, Pankuch M, Hartsell W, Chang J, Hahn K, Abruscato L. Examining Uniform Scanning PBT Combined with 6 MeV EBT to Deliver 50 Gy(RBE) with a SIB. Particle Therapy Cooperative Group (PTCOG) Symposium-Annual Meeting; May 14-19, 2012; Seoul, Korea. Conference Presentation2012
REG001Pediatrics/CNSConfer M, McNall-Knapp R, Krishnan S, Gross N, Keole S. Proton Radiotherapy for Pediatric craniopharyngioma Initial Result. 2012 International Symposium on Pediatric Neuro-Oncology.-Annual Meeting; June 24-27, 2012; Toronto, Canada. Conference Presentation2012
REG001GenitourinaryVargas C, Hartsell W, Hahn K, Smidbush D, Chang J, Abruscato L, Piper A, Keole S. Hyopfractionated vs. Standard Fractionation Proton Therapy for Prostate Cancer: PCG GU002-10.Amer Soc Thera Rad Onc (ASTRO) Symposium-Annual Meeting; Oct 28-31, 2012; Boston, MA-USA .Conference Presentation2012
REG001PhysicsRendall R, Curran L, Chang J, Gao M, Spring D, Yoo C, Pankuch M, Hartsell W. Contrast Filled Rectal Balloons in Post-Prostatectomy Proton Therapy Alignment Particle Therapy Cooperative Group (PTCOG) Symposium-Annual Meeting; May 14-19, 2012; Seoul, Korea. Conference Presentation2012
REG001PhysicsSchenkenfelder P, Schmidt S, Sweeney P. A Techniqu for the Isocentric Treatment of Pelvic Nodes for High Risk Prostate Cancer using Fixed Beam Line Proton Radiotherapy. American Association of Medical Dosismetrists Symposium-Annual Meeting; June 10-14, 2012; Atlanta, Georgia-USA. Conference Presentation2012
REG001PhysicsHsi W, Vargas C, O'Ryan-Blair A, Schreuder A. Planning techniques of proton boost for treating oropharynx tumors of head and neck cancers. Particle Therapy Cooperative Group (PTCOG) Symposium-Annual Meeting; May 14-19, 2012; Seoul, Korea. Conference Presentation2012